# Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493

> **NCT00952094** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** KRN1493

## Key facts

- **NCT ID:** NCT00952094
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-01
- **Final completion:** 2009-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2009-08-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952094, "Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00952094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*